Evidence map›Paper›PMID 34880314›Full record

ArticleScientific reports2021

A proteomics study identifying interactors of the FSHD2 gene product SMCHD1 reveals RUVBL1-dependent DUX4 repression.

Remko Goossens, Mara S Tihaya, Anita van den Heuvel, Klorane Tabot-Ndip, Iris M Willemsen, Stephen J Tapscott, Román González-Prieto, Jer-Gung Chang, Alfred C O Vertegaal, Judit Balog and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Remko GoossensDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Mara S TihayaDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Anita van den HeuvelDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Klorane Tabot-NdipDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Iris M WillemsenDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Stephen J TapscottHuman Biology Division, Fred Hutchinson Cancer Research Center, Seattle, USA.
Román González-PrietoDepartment of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands.
Jer-Gung ChangDepartment of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands.
Alfred C O VertegaalDepartment of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands.
Judit BalogDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. J.Balog@lumc.nl.
Silvère M van der MaarelDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands. S.M.van_der_Maarel@lumc.nl.
Leiden University Medical Center · NLSeattle University · US

Funding

SMCHD1 Pathways as Candidate Targets for FSHDR01AR066248 · NIAMS · FRED HUTCHINSON CANCER RESEARCH CENTER · PI TAPSCOTT, STEPHEN J · 2014 to 2024
$4.5M
NIAMS NIH HHS R01 AR066248
6 · The paper itself

Abstract

Structural Maintenance of Chromosomes Hinge Domain Containing 1 (SMCHD1) is a chromatin repressor, which is mutated in > 95% of Facioscapulohumeral dystrophy (FSHD) type 2 cases. In FSHD2, SMCHD1 mutations ultimately result in the presence of the cleavage stage transcription factor DUX4 in muscle cells due to a failure in epigenetic repression of the D4Z4 macrosatellite repeat on chromosome 4q, which contains the DUX4 locus. While binding of SMCHD1 to D4Z4 and its necessity to maintain a repressive D4Z4 chromatin structure in somatic cells are well documented, it is unclear how SMCHD1 is recruited to D4Z4, and how it exerts its repressive properties on chromatin. Here, we employ a quantitative proteomics approach to identify and characterize novel SMCHD1 interacting proteins, and assess their functionality in D4Z4 repression. We identify 28 robust SMCHD1 nuclear interactors, of which 12 are present in D4Z4 chromatin of myocytes. We demonstrate that loss of one of these SMCHD1 interacting proteins, RuvB-like 1 (RUVBL1), further derepresses DUX4 in FSHD myocytes. We also confirm the interaction of SMCHD1 with EZH inhibitory protein (EZHIP), a protein which prevents global H3K27me3 deposition by the Polycomb repressive complex PRC2, providing novel insights into the potential function of SMCHD1 in the repression of DUX4 in the early stages of embryogenesis. The SMCHD1 interactome outlined herein can thus provide further direction into research on the potential function of SMCHD1 at genomic loci where SMCHD1 is known to act, such as D4Z4 repeats, the inactive X chromosome, autosomal gene clusters, imprinted loci and telomeres.

Indexed as

ATPases Associated with Diverse Cellular ActivitiesCarrier ProteinsCell Line, TumorChromosomal Proteins, Non-HistoneDNA HelicasesGene Expression Regulation, DevelopmentalHEK293 CellsHomeodomain ProteinsHumansMuscular Dystrophy, FacioscapulohumeralProtein BindingProteomicsATPases Associated with Diverse Cellular ActivitiesCarrier ProteinsChromosomal Proteins, Non-HistoneDNA HelicasesDUX4L1 protein, humanHomeodomain ProteinsRUVBL1 protein, humanSMCHD1 protein, human

Identifiers

PMID34880314
PMCPMC8654949
OpenAlexW4200607917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.